Axa lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 553.0% during the 4th quarter, HoldingsChannel reports. The fund owned 7,745 shares of the medical technology company’s stock after buying an additional 6,559 shares during the period. Axa’s holdings in Teleflex were worth $1,927,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Comerica Bank raised its position in shares of Teleflex by 0.6% during the 4th quarter. Comerica Bank now owns 35,546 shares of the medical technology company’s stock worth $9,778,000 after acquiring an additional 198 shares in the last quarter. Chartwell Investment Partners LLC raised its position in shares of Teleflex by 3.9% during the 3rd quarter. Chartwell Investment Partners LLC now owns 5,444 shares of the medical technology company’s stock worth $1,317,000 after acquiring an additional 204 shares in the last quarter. Creative Planning raised its position in shares of Teleflex by 6.0% during the 4th quarter. Creative Planning now owns 4,119 shares of the medical technology company’s stock worth $1,025,000 after acquiring an additional 234 shares in the last quarter. Barometer Capital Management Inc. raised its position in shares of Teleflex by 3.2% during the 4th quarter. Barometer Capital Management Inc. now owns 8,075 shares of the medical technology company’s stock worth $2,009,000 after acquiring an additional 250 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado raised its position in shares of Teleflex by 0.3% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 109,748 shares of the medical technology company’s stock worth $27,307,000 after acquiring an additional 286 shares in the last quarter. 90.75% of the stock is currently owned by institutional investors and hedge funds.
Several brokerages have recently weighed in on TFX. Leerink Swann reissued a “buy” rating and set a $321.00 target price (up previously from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. Stephens reissued a “buy” rating and set a $300.00 target price on shares of Teleflex in a research report on Thursday, January 18th. TheStreet lowered Teleflex from an “a-” rating to a “c+” rating in a research report on Monday, March 12th. Finally, ValuEngine lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the stock. Teleflex currently has a consensus rating of “Hold” and a consensus price target of $281.56.
In other Teleflex news, Director George Babich, Jr. sold 2,500 shares of Teleflex stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $268.53, for a total transaction of $671,325.00. Following the transaction, the director now owns 11,083 shares of the company’s stock, valued at $2,976,117.99. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $248.96, for a total value of $49,792.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at approximately $2,011,596.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,259 shares of company stock worth $3,760,536. 2.39% of the stock is currently owned by corporate insiders.
TFX stock opened at $265.28 on Wednesday. The company has a market capitalization of $11,927.25, a P/E ratio of 81.13, a price-to-earnings-growth ratio of 1.96 and a beta of 1.22. Teleflex Incorporated has a 12-month low of $191.04 and a 12-month high of $288.78. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.51 and a current ratio of 2.33.
Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $2.44 EPS for the quarter, topping the consensus estimate of $2.40 by $0.04. The company had revenue of $595.10 million for the quarter, compared to analyst estimates of $601.17 million. Teleflex had a return on equity of 16.46% and a net margin of 7.11%. The firm’s revenue was up 15.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.13 earnings per share. equities analysts expect that Teleflex Incorporated will post 9.67 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Thursday, March 15th. Shareholders of record on Friday, March 2nd were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.51%. The ex-dividend date was Thursday, March 1st. Teleflex’s dividend payout ratio (DPR) is 41.59%.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.